Impact of prior systemic therapy on PFS patients enrolled in FIGHT-202

• Date :
• 2    
  0

BEACON CRC: first-line bevacizumab in colorectal cancer treatment

• Date :
• 2    
  0

VALENTINO: VAF as prognostic marker in mCRC

• Date :
• 2    
  0

Updates to look out for at ESMO WCGIC 2021

• Date :
• 2    
  0

CRC highlights from ESMO WCGIC 2021

• Date :
• 1    
  0

Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastases

• Date :
• 1    
  0

Tiragolumab and atezolizumab in metastatic esophageal cancer

• Date :
• 1    
  0

Early colon and rectal cancer at ESMO WCGIC 2021

• Date :
• 1    
  0

Liquid biopsies in mCRC

• Date :
• 1    
  0

Implications of antibiotic consumption on early-onset CRC

• Date :
• 1    
  0

Antibiotic usage and incidence of CRC

• Date :
• 1    
  0

Adjuvant chemotherapy in gastric adenocarcinoma

• Date :
• 1    
  0

KEYNOTE-811: trastuzumab + chemotherapy with or without pembrolizumab for HER2+ G/GEJ cancer

• Date :
• 0    
  0

MATTERHORN: neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable G/GEJ

• Date :
• 0    
  0

Averectal: neoadjuvant short-course RT followed by chemo + avelumab in rectal adenocarcinoma

• Date :
• 0    
  0

Treatment of CRC in adjuvant setting

• Date :
• 0    
  0

Tislelizumab in patients with unresectable HCC demonstrates durable responses

• Date :
• 0    
  0

1L NALIRIFOX in advanced or metastatic PDAC

• Date :
• 0    
  0

Impact of gender and HPV status on anal squamous cell carcinoma survival

• Date :
• 0    
  0

Monitoring MRD by ctDNA in resectable CRC

• Date :
• 0    
  0

Treating CRC with regorafenib in Latin America

• Date :
• 0    
  0

Americas Hepato-Pancreato-Biliary Association Annual Meeting - AHPBA 2025

• Date :
• 1152    
  0

Eus Endos International Live Cours 2024

• Date :
• 1412    
  0

VirtualEndo24 - The Global View 2024

• Date :
• 6702    
  0

BSG LIVE’24

• Date :
• 5601    
  0

DIGESTIVE DISEASE WEEK - DDW 2024

• Date :
• 4344    
  0